Cardea Bio accelerates commercial platform due to demand from market moving partners
/PRNewswire/ -- To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of its brand new BPU™ (Biosignal Processing Unit)...
Source: prnewswire.com